Cronos Group Inc. to Speak at Bernstein's 40th Annual Strategic Decisions Conference
Cronos Group announced that its Chairman, President, and CEO, Mike Gorenstein, will speak at Bernstein's 40th Annual Strategic Decisions Conference. The event is scheduled for May 30, 2024, at 2:30 PM ET. Attendees can access a live webcast on the Investors section of Cronos Group’s website. This participation underscores Cronos' commitment to investor engagement and strategic communication.
- Participation in Bernstein's 40th Annual Strategic Decisions Conference enhances visibility among investors.
- Opportunity for direct communication with investors and analysts.
- Live webcast allows for broader access and engagement from a global audience.
- No immediate impact on revenue or profitability disclosed.
- Potential overemphasis on PR without substantive new information.
- The focus on an event may not address underlying business challenges or market conditions.
TORONTO, May 29, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at Bernstein's 40th Annual Strategic Decisions Conference on Thursday, May 30, 2024, at 2:30PM ET.
A live webcast will be available on the Investors section of the Company’s website at https://ir.thecronosgroup.com/events-presentations.
About Cronos Group Inc.
Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach®, PEACE NATURALS® and Lord Jones®. For more information about Cronos and its brands, please visit: thecronosgroup.com.
Forward-looking Statements
This press release may contain information that may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws and court decisions (collectively, “Forward-looking Statements”). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe” or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Some of the Forward-looking Statements contained in this press release include statements about Cronos’ intention to build an international iconic brand portfolio and develop disruptive intellectual property. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, results, performance or achievements expressed or implied by those Forward-looking Statements and the Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, and quarterly report on Form 10-Q for the quarter ended March 31, 2024, which have been filed on SEDAR and EDGAR and can be accessed at www.sedar.com and www.sec.gov/edgar, respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement.
Cronos Group Contact
Shayne Laidlaw
Investor Relations
Tel: (416) 504-0004
investor.relations@thecronosgroup.com
FAQ
When will Cronos Group speak at Bernstein's 40th Annual Strategic Decisions Conference?
How can I watch Cronos Group's presentation at the Bernstein Conference?
What is the significance of Cronos Group participating in the Bernstein Conference?